Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001255294-12-000340
Filing Date
2012-05-21
Accepted
2012-05-21 11:07:27
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q 421276
2 GRAPHIC image_001.jpg GRAPHIC 5418
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 8024
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 8006
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 4163
  Complete submission text file 0001255294-12-000340.txt   2356101

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ambs-20120331.xml EX-101.INS 424112
7 XBRL SCHEMA FILE ambs-20120331.xsd EX-101.SCH 12451
8 XBRL DEFINITION FILE ambs-20120331_def.xml EX-101.DEF 7751
9 XBRL LABEL FILE ambs-20120331_lab.xml EX-101.LAB 76757
10 XBRL PRESENTATION FILE ambs-20120331_pre.xml EX-101.PRE 58571
Mailing Address 675 ALMANOR AVE. SUNNYVALE CA 94085
Business Address 675 ALMANOR AVE. SUNNYVALE CA 94085 (408) 737-2734
Amarantus BioSciences, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-148922 | Film No.: 12857357
SIC: 2834 Pharmaceutical Preparations